{"nct_id":"NCT01838395","title":"Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2013-04","start_date_type":"ACTUAL","primary_completion_date":"2016-03","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BLRX"]}